Junho Pak

FDA investigator · also recorded as Jun Park

Appears on 28 documents from 2012 to 2026, most often at sites in India. Most often cites general requirements (21 CFR 211.160).

28
Documents on file
4.4
Observations per 483
2012
First seen
2026
Most recent

What they cite most

From 124 observations

Activity by year

2012: 1, 2015: 2, 2017: 2, 2018: 4, 2019: 2, 2020: 3, 2021: 2, 2022: 5, 2023: 3, 2024: 1, 2025: 2, 2026: 1

Where

India 7 · Pennsylvania 6 · Maryland 2 · New Jersey 2 · New York 2 · California 1

Is Junho Pak coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

28 documents, newest first
FirmOpen
483 Frontage Laboratories, Inc.Apr 14, 2026
483 Eli Lilly and CompanyMay 20, 2025 · Indianapolis, Indiana
483 PCI San Diego, Inc.May 9, 2025 · San Diego, California
483 Sun Pharmaceutical Medicare LimitedFeb 27, 2024 · Halol Panchmahal, India
483 Apitoria Pharma Private LimitedMay 19, 2023 · Anakapalli, India
483 DR. REDDY'S LABORATORIES LIMITEDMay 12, 2023 · Srikakulam, India
483 PEL Healthcare LLCJan 13, 2023 · Sellersville, Pennsylvania

About this profile

What does Junho Pak inspect?

Junho Pak appears on 28 documents on file covering 28 sites, most often in India.

What do they cite most often?

21 CFR 211.160 (general requirements), followed by 21 CFR 211.68 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Junho Pak is dated Apr 14, 2026.

FDA Investigator Junho Pak: 483s & Inspections · FDA Intel